As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications
and international access improves, the number of HCTs performed annually continues to …

Purpose The changes in the recommended use of radiation therapy (RT) in the presence of
expanding systemic cancer therapies and technological advances are poorly characterized …

Background: Older adults account for 70% of cancer-related deaths, but previous studies
have shown that they are underrepresented in cancer clinical trials. We sought to analyze …

Background: We evaluated the relative attribution and interactions of treatment and patient-
related risk factors for second primary malignancies (SPMs) in cervical and endometrial …

Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed
and developing countries. The incidence of pancreatic cancer in China accounts for about a …

PURPOSE New cancer therapies are frequently evaluated in multiple disease indications.
We evaluated whether the probability of achieving US Food and Drug Administration (FDA) …

Objectives Clinical and imaging examinations frequently have indeterminate results during
cancer surveillance, which can lead to overtreatment and cause psychological and financial …

Objectives Some therapeutic strategy questions in oncology could be answered with studies
using observational data. Target trial emulation is the application of design principles from …

Simple Summary The aim of our work is to describe the level of evidence supporting
therapeutic recommendations in United States pancreatic adenocarcinoma guidelines, and …

Abstract Purpose The National Comprehensive Cancer Network (NCCN) clinical guidelines
influence medical practice, payor coverage, and standards of care. The levels of evidence …